Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. My ...

Nvidia has turned its balance sheet into a weapon, using minority stakes and strategic alliances to lock in demand for its ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Discover how an inflation-focused asset allocation model is evolving for 2026 with added diversification using all-weather ...

Historically, pricey markets have generated weaker 10-year average annual returns. It means investors must be more mindful of their investment strategies. In other words, throwing a dart at a list of ...

I rely on data for clarity and risk transparency, but instinct shapes how I interpret it. My approach combines analytical ...